Study Fails to Confirm L-Carnitine Benefits in Dialysis Patients

Share this article:

A new meta-analysis has found that L-carnitine does not significantly increase hemoglobin or decrease the required erythropoietin dose in patients on maintenance hemodialysis (MHD), contrary to a previous meta-analysis. L-cartinine, however, significantly decreases serum levels of low-density lipoprotein (LDL) and C-reactive protein (CRP).

Yizhi Chen, MD, of the Chinese People's Liberation Army Medical Academy in Beijing, and collaborators analyzed data from 49 randomized controlled trials examining the effects of L-carnitine in adult MHD patients. L-carnitine decreased the mean LDL level by 5.82 mg/dL and mean CRP level by 3.65 mg/L, the investigators reported online ahead of print in the American Journal of Clinical Nutrition. L-carnitine had no significant effect on triglycerides, total cholesterol, high-density lipoprotein, hemoglobin, hematocrit, albumin, or the required erythropoietin dose.

Share this article:
You must be a registered member of RUN to post a comment.

More in Hemodialysis

Uremic Toxin in Hemodialysis Patients Predicts Heart Failure Risk

Uremic Toxin in Hemodialysis Patients Predicts Heart Failure ...

High levels of indoxyl sulfate are associated with a more than 5-fold increased risk of a first heart failure event.

Severe Adverse Technical Events Rare in Home Hemodialysis

Severe Adverse Technical Events Rare in Home Hemodialysis

Study reveals a rate of 0.038 such events per 1,000 home dialysis treatments.

Home Dialysis On the Rise Despite High Cost

Home Dialysis On the Rise Despite High Cost

Experts say that issues of cost to providers have prevented broader application of home dialysis.